Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel, Carboplatin and Gemcitabine in Locally Advanced Bladder Cancer
NCT00136175Phase 2Completed
- Sponsor
- University of Michigan Rogel Cancer Center
- Start
- Nov 1999
- Primary completion
- Dec 2005
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, carboplatin, gemcitabine in bladder cancer, sponsored by University of Michigan Rogel Cancer Center. Started Nov 1999; status: completed.
02
Drugs
paclitaxelcarboplatingemcitabine
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT00136175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00136175.